The use of human menopausal and chorionic gonadotropins for induction of ovulation. Sixteen year' experience at the Sloane Hospital for Women

M. Schwartz; R. Jewelewicz; I. Dyrenfurth; P. Tropper; R. L. Vande Wiele

doi:10.1016/S0002-9378(16)32740-5

The use of human menopausal and chorionic gonadotropins for induction of ovulation. Sixteen year' experience at the Sloane Hospital for Women

M. Schwartz, R. Jewelewicz, I. Dyrenfurth, P. Tropper, R. L. Vande Wiele

Research output: Contribution to journal › Article › peer-review

63 Scopus citations

Abstract

Gonadotropin therapy for anovulation is highly successful: 58.6% of treated patients conceive. Better results are achieved in patients with galactorrhea-amenorrhea (77.1%) and hypogonadotropic hypogonadism (63.3%) than in patients with normal gonadotropin levels (45.4%). The spontaneous abortion rate (27.5%) is somewhat higher than that in spontaneous pregnancies. The multiple pregnancy rate is 31% and was slightly lower in cycles with preovulatory estrogen levels in the physiologic range. In patients treated with human menopausal and chorionic gonadotropins for 7 to 9 days per cycle, the multiple pregnancy rate is considerably less (12.9%) than in patients with longer treatment. The efficacy of treatment does not diminish with repeat-treatment cycles.

Original language	English (US)
Pages (from-to)	801-807
Number of pages	7
Journal	Unknown Journal
Volume	138
Issue number	7 I
DOIs	https://doi.org/10.1016/S0002-9378(16)32740-5
State	Published - 1980
Externally published	Yes

ASJC Scopus subject areas

Obstetrics and Gynecology

Access to Document

10.1016/S0002-9378(16)32740-5

Cite this

@article{17f65a05c62d44dbb866225da558ba9a,

title = "The use of human menopausal and chorionic gonadotropins for induction of ovulation. Sixteen year' experience at the Sloane Hospital for Women",

abstract = "Gonadotropin therapy for anovulation is highly successful: 58.6% of treated patients conceive. Better results are achieved in patients with galactorrhea-amenorrhea (77.1%) and hypogonadotropic hypogonadism (63.3%) than in patients with normal gonadotropin levels (45.4%). The spontaneous abortion rate (27.5%) is somewhat higher than that in spontaneous pregnancies. The multiple pregnancy rate is 31% and was slightly lower in cycles with preovulatory estrogen levels in the physiologic range. In patients treated with human menopausal and chorionic gonadotropins for 7 to 9 days per cycle, the multiple pregnancy rate is considerably less (12.9%) than in patients with longer treatment. The efficacy of treatment does not diminish with repeat-treatment cycles.",

author = "M. Schwartz and R. Jewelewicz and I. Dyrenfurth and P. Tropper and {Vande Wiele}, {R. L.}",

year = "1980",

doi = "10.1016/S0002-9378(16)32740-5",

language = "English (US)",

volume = "138",

pages = "801--807",

journal = "Unknown Journal",

issn = "0946-672X",

publisher = "Urban und Fischer Verlag GmbH und Co. KG",

number = "7 I",

}

TY - JOUR

T1 - The use of human menopausal and chorionic gonadotropins for induction of ovulation. Sixteen year' experience at the Sloane Hospital for Women

AU - Schwartz, M.

AU - Jewelewicz, R.

AU - Dyrenfurth, I.

AU - Tropper, P.

AU - Vande Wiele, R. L.

PY - 1980

Y1 - 1980

N2 - Gonadotropin therapy for anovulation is highly successful: 58.6% of treated patients conceive. Better results are achieved in patients with galactorrhea-amenorrhea (77.1%) and hypogonadotropic hypogonadism (63.3%) than in patients with normal gonadotropin levels (45.4%). The spontaneous abortion rate (27.5%) is somewhat higher than that in spontaneous pregnancies. The multiple pregnancy rate is 31% and was slightly lower in cycles with preovulatory estrogen levels in the physiologic range. In patients treated with human menopausal and chorionic gonadotropins for 7 to 9 days per cycle, the multiple pregnancy rate is considerably less (12.9%) than in patients with longer treatment. The efficacy of treatment does not diminish with repeat-treatment cycles.

AB - Gonadotropin therapy for anovulation is highly successful: 58.6% of treated patients conceive. Better results are achieved in patients with galactorrhea-amenorrhea (77.1%) and hypogonadotropic hypogonadism (63.3%) than in patients with normal gonadotropin levels (45.4%). The spontaneous abortion rate (27.5%) is somewhat higher than that in spontaneous pregnancies. The multiple pregnancy rate is 31% and was slightly lower in cycles with preovulatory estrogen levels in the physiologic range. In patients treated with human menopausal and chorionic gonadotropins for 7 to 9 days per cycle, the multiple pregnancy rate is considerably less (12.9%) than in patients with longer treatment. The efficacy of treatment does not diminish with repeat-treatment cycles.

UR - http://www.scopus.com/inward/record.url?scp=0019132409&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019132409&partnerID=8YFLogxK

U2 - 10.1016/S0002-9378(16)32740-5

DO - 10.1016/S0002-9378(16)32740-5

M3 - Article

C2 - 6778212

AN - SCOPUS:0019132409

SN - 0946-672X

VL - 138

SP - 801

EP - 807

JO - Unknown Journal

JF - Unknown Journal

IS - 7 I

ER -

The use of human menopausal and chorionic gonadotropins for induction of ovulation. Sixteen year' experience at the Sloane Hospital for Women

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this